by Q1Web Admin | Jun 14, 2017 | News
Celenge has announced positive results of its phase 2 clinical trial treating systematic lupus erythematosus (SLE), more commonly referred to as lupus. The drug, C-220, an oral immune-modulatory compound showed greater disease state improvement when compared with...
by Q1Web Admin | Jun 14, 2017 | News
The Food and Drug Administration (FDA) has requested Endo Pharmaceuticals to take their opioid painkiller, Opana ER, off the market. The drug has been linked to various disease outbreaks as well has heavy opioid abuse through users who crush and inject the pill. FDA...
by Q1Web Admin | Jun 14, 2017 | News
The European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency External link icon (PMDA) and the United States’ Food and Drug Administration External link icon (FDA) have announced a partnership to combat antibiotic resistance. The...
by Q1Web Admin | Jun 13, 2017 | Blog, Pharmaceutical
Pharma’s Patient Package: How the Patient Centricity is Changing the Industry How the Patient Centricity is Changing the Pharmaceutical Industry Over the past few years, drug makers have partnered with patients to deliver better drugs, gain more feedback, and...
by Q1Web Admin | Jun 12, 2017 | Uncategorized
Navigating Promotional Content Review: FDA Warnings, Stakeholder Needs, and Social Media at Allergan Navigating Promotional Content Review: FDA Warnings, Stakeholder Needs, and Social Media at Allergan Medical information remains highly regulated in 2017. With...
